Total Payments
$5,161
2024 Payments
$1,694
Companies
30
Transactions
318
Medicare Patients
234
Medicare Billing
$18,066
Payment Breakdown by Category
Food & Beverage$5,150 (99.8%)
Education$11.71 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,150 | 317 | 99.8% |
| Education | $11.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,126 | 90 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,028 | 40 | $0 (2024) |
| Lilly USA, LLC | $594.62 | 38 | $0 (2024) |
| Novo Nordisk Inc | $449.77 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $320.04 | 23 | $0 (2024) |
| Amgen Inc. | $269.05 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $163.68 | 10 | $0 (2024) |
| PFIZER INC. | $159.23 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $152.30 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $120.15 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,694 | 101 | AstraZeneca Pharmaceuticals LP ($372.76) |
| 2023 | $1,365 | 78 | ABBVIE INC. ($338.99) |
| 2022 | $1,031 | 61 | AstraZeneca Pharmaceuticals LP ($243.00) |
| 2021 | $1,071 | 78 | AbbVie Inc. ($232.38) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes Care | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.61 | General |
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Obesity | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Bone Health | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 99 | $9,824 | $4,651 |
| 2022 | 2 | 57 | 103 | $10,404 | $4,229 |
| 2021 | 2 | 51 | 101 | $9,910 | $4,866 |
| 2020 | 2 | 75 | 120 | $11,045 | $4,320 |
Total Patients
234
Total Services
423
Medicare Billing
$18,066
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 74 | $7,474 | $3,648 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 25 | $2,350 | $1,003 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 69 | $7,185 | $3,044 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 34 | $3,219 | $1,185 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 73 | $7,590 | $3,871 | 51.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 28 | $2,320 | $995.84 | 42.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 34 | 61 | $6,675 | $2,711 | 40.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 41 | 59 | $4,370 | $1,608 | 36.8% |
About Natalie Roby, N.P
Natalie Roby, N.P is a Family healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831273929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Natalie Roby, N.P has received a total of $5,161 in payments from pharmaceutical and medical device companies, with $1,694 received in 2024. These payments were reported across 318 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,150).
As a Medicare-enrolled provider, Roby has provided services to 234 Medicare beneficiaries, totaling 423 services with total Medicare billing of $18,066. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Ontario, OH
- Active Since 10/25/2006
- Last Updated 11/18/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1831273929
Products in Payments
- FARXIGA (Drug) $512.35
- UBRELVY (Drug) $480.19
- VRAYLAR (Drug) $415.91
- TRELEGY ELLIPTA (Drug) $278.36
- QULIPTA (Drug) $229.88
- TRULICITY (Drug) $199.85
- JARDIANCE (Drug) $191.12
- BREZTRI (Drug) $187.58
- Wegovy (Drug) $184.68
- FASENRA (Biological) $170.26
- Kerendia (Drug) $163.68
- Otezla (Drug) $162.11
- TRINTELLIX (Drug) $152.30
- ELIQUIS (Drug) $143.42
- Rybelsus (Drug) $123.03
- XIFAXAN (Drug) $120.15
- EMGALITY (Drug) $105.08
- NURTEC ODT (Drug) $101.78
- MOUNJARO (Drug) $97.14
- BEVESPI AEROSPHERE (Drug) $81.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ontario
Amber Campbell, Cnp, CNP
Family — Payments: $8,036
Family $8,036
Patty Fleming, Cnp, CNP
Family — Payments: $4,259
Family $4,259
Mrs. Julie Burkhart, Aprn, Np-C, APRN, NP-C
Family — Payments: $3,466
Family $3,466
Kiersten Hogg, Dnp, Fnp, DNP, FNP
Family — Payments: $2,728
Family $2,728
Mr. Michael Conley, Np, NP
Family — Payments: $2,477
Family $2,477
Martha Ruiz, Fnp, FNP
Family — Payments: $1,843
Family $1,843